National Storage Affiliates Trust, a REIT focused on acquiring and owning self-storage properties, announced terms for its IPO on Monday. The Greenwood Village, CO-based company plans to raise $320 million by offering 20 million shares at a price range of...read more
Four companies publicly listed on US markets during the last full week of the first quarter, raising $510 million.
Solar tech provider SolarEdge outshined its peers while mega biotech Cellectis saw speculators jump in before the IPO and then quickly jump out....read more
Jernigan Capital, a recently formed REIT focused on lending to self-storage facilities, raised $100 million by offering 5 million shares at $20, the midpoint of the $19-$21 range. Jernigan Capital plans to list on the NYSE under the symbol JCAP. Raymond James ...read more
In the last full week of the first quarter, the IPO market could see a billion-dollar cancer biotech and a producer of optimized solar power technology.
Three health care IPOs: a mega biotech and two small medical devices
Pre-clinical immunotherapy biotech ...read more
NSA sets terms for $320 million IPO; storage REIT roll-up to go public
National Storage Affiliates Trust, a REIT focused on acquiring and owning self-storage properties, announced terms for its IPO on Monday. The Greenwood Village, CO-based company plans to raise $320 million by offering 20 million shares at a price range of...read more
US IPO Weekly Recap: SolarEdge shines while other IPOs fall flat
Four companies publicly listed on US markets during the last full week of the first quarter, raising $510 million. Solar tech provider SolarEdge outshined its peers while mega biotech Cellectis saw speculators jump in before the IPO and then quickly jump out....read more
Jernigan Capital prices IPO at $20 midpoint
Jernigan Capital, a recently formed REIT focused on lending to self-storage facilities, raised $100 million by offering 5 million shares at $20, the midpoint of the $19-$21 range. Jernigan Capital plans to list on the NYSE under the symbol JCAP. Raymond James ...read more
Week ahead: Up to 9 IPOs during the week of March 23 led by a billion-dollar biotech
In the last full week of the first quarter, the IPO market could see a billion-dollar cancer biotech and a producer of optimized solar power technology. Three health care IPOs: a mega biotech and two small medical devices Pre-clinical immunotherapy biotech ...read more